QuEra Computing
Hardware-led quantum compute: cloud access (QPU-seconds on AWS Braket), on-premises Gemini-class system sales (e.g. AIST Japan), enterprise R&D engagements (Merck, Amgen), and government contracts (DARPA QBI). Pre-revenue-scale; transitioning from research org to commercial enterprise (FY25).
QuEra Computing (private, neutral-atom quantum; Boston/Harvard-MIT spinout) has NO disclosed priced-equity valuation. The valuation trail is genuinely sparse and every concrete number is an inference, not a company disclosure. KEY FACT — the big raise is a convertible note, not a priced round. The Feb 11, 2025 '$230M+ financing' (later expanded; $60M tranche milestone-contingent) is explicitly a CONVERTIBLE NOTE that converts to equity at QuEra's NEXT equity round (confirmed by QuEra's own COO and by TechCrunch). A convertible note has no priced post-money. The company expressly DECLINED to disclose a valuation, saying only it was 'a very substantial increase' over prior funding. The single point above is therefore a SECONDARY/INFERRED mark, not a real priced post-money: aggregators (Tracxn, CB Insights, Latka) list QuEra as a ~$1B 'unicorn' as of Feb 2025 and label the round 'Series B', but that figure is not a disclosed priced valuation — it appears to be a note cap / unicorn-list inference. Conflicting estimate: TechCrunch's own reporter speculated the implied valuation 'might be' ~$400M (conservative), explicitly flagging uncertainty due to the note structure. So the real range is roughly $400M (press estimate) to $1B (aggregator unicorn mark) — I plotted the $1B aggregator figure but it should be read as a soft ceiling, not a confirmed mark. OMITTED (no valuation ever disclosed — not invented): - 2021-11-17 seed/'Series B' $17M (Rakuten-led, with Day One Ventures, Frontiers Capital): amount confirmed by TechCrunch + QuEra, but NO post-money disclosed. - 2023 round: QuEra's CEO references 'our last funding round in 2023' but the amount AND valuation are both undisclosed. (Total pre-2025 raised was 'just under $50M' per TechCrunch.) SECONDARY MARKET: QuEra trades on Forge, Hiive, and Nasdaq Private Market, but no specific implied per-share or implied-valuation figure was retrievable (Forge/Hiive pages are gated; search surfaced only qualitative 'demand outstrips supply' language). No usable secondary mark. NOT a de-SPAC: no S-4/proxy/investor deck exists (QuEra is venture-backed private, no SPAC merger). Total funding cited as ~$247M across rounds. Confidence LOW: the lone plotted point rests on an unpriced instrument with a company-declined valuation; the '$1B' is aggregator inference and conflicts with a credible ~$400M press estimate.
Earnings, margins, COGS & capex
Revenue trend
Margins
Bull & bear
The best-capitalized, most scientifically-validated neutral-atom pure-play, with a logical-qubit lead and a credit-worthy 2028 fault-tolerance roadmap — backed by Google, SoftBank, and NVIDIA, and channel-distributed via AWS Braket.
- Logical-qubit leadership: demonstrated algorithms with up to 96 logical qubits on a 448-physical-qubit array with below-threshold (error-corrected) performance — a published, peer-reviewable lead over most pure-play rivals on the metric that actually matters (logical, not raw physical, qubits) (FY25 / Dec 2025).
- Neutral-atom is the modality that has matched superconducting and trapped-ion roadmaps on qubit count while delivering real logical-qubit demonstrations; QuEra ran a 3,000-qubit array continuously for 2+ hours with mid-computation atom replenishment (FY25) — a hard scaling milestone.
- Blue-chip backing de-risks capital: Google Quantum AI + SoftBank Vision Fund 2 led $230M+ (Feb 2025), NVIDIA's NVentures joined the expanded round (Sept 2025) — strategic validation plus a hybrid quantum-classical GPU pathway with NVIDIA.
- Channel + provenance moat: Aquila was the first neutral-atom QPU on AWS Braket (since 2022); the FTQC Libra system is committed to Braket for 2028. The science traces to the Lukin (Harvard) / Vuletić (MIT) groups via an exclusive Harvard OTD patent license — a deep IP + talent moat.
- Government tailwind: advanced to Stage B of DARPA's Quantum Benchmarking Initiative (1 of 11; up to $15M), and US policy is moving toward direct quantum funding/equity stakes (2026) — a non-dilutive demand + validation channel.
A pre-commercial-scale, cash-burning hardware bet whose ~$1B 'valuation' is an unpriced convertible-note mark — fault tolerance is still 2+ years out, revenue is unverified and tiny, and well-funded incumbents (IBM, Google, Quantinuum) plus same-modality rivals (Pasqal, Atom Computing) crowd the field.
- Valuation is soft: the $230M+ is a convertible note, not a priced equity round, so the ~$1B figure is an implied secondary mark — there is no investor who set that price in a Series round. Down-round risk at conversion if the quantum hype cycle deflates.
- Revenue is unverified and immaterial: QuEra discloses only 'record revenues and cash collections' with no number; the ~$39.9M ARR is a third-party (getLatka) estimate, not a filing. Public neutral-atom peer Infleqtion's SPAC filings show how thin real quantum revenue is — even IonQ, the largest public pure-play, did only ~$130M in 2025.
- Fault tolerance is a 2028 promise, not a product: the commercial product today is analog Aquila (256 qubits); megaquop/256-logical (Libra) is targeted for 2028 and gigaquop/1,000+ logical for 2028-29. Any slip pushes the commercial inflection years out while burn continues.
- Crowded, deep-pocketed competition: IBM, Google, and Quantinuum out-resource QuEra across modalities; within neutral-atom, Pasqal (hit 1,000 qubits 2024, France) and Atom Computing (Microsoft Azure partnership) compete directly. Modality could still lose to superconducting/ion-trap on fidelity or to photonics on networking.
- Public-market comps signal froth: IonQ/Rigetti/D-Wave trade at P/S of ~100-800x (May 2026) and analysts warn of a crash — QuEra IPO-ing into that tape, or a deflation of it, caps the realistic exit multiple and the convertible-note conversion price.
What it is worth
Pre-revenue private quantum pure-play — valued on a scenario range anchored to (a) the ~$1B convertible-note implied secondary mark (2025), (b) public neutral-atom/pure-play comps (IonQ ~$130M FY25 rev at frothy ~100x+ P/S; Infleqtion SPAC mark), and (c) capital raised (~$247M). No DCF — cash flows are negative and the value is entirely a function of probability-weighted FTQC milestones, not near-term earnings.
~$0.4-0.8B
quantum sentiment deflates (public peers crash from 100-800x P/S), the note converts at a down-round, and a roadmap slip on Libra pushes the commercial inflection past 2028; value reverts toward capital-raised.
~$1-1.5B
the convertible note converts at a modestly stepped-up priced round as milestones progress but fault tolerance remains pre-commercial; valuation tracks the implied 2025 mark with a small premium for the 96-logical-qubit result.
~$2.5-4B
if the 2028 Libra fault-tolerant system lands on Braket on schedule and QuEra IPOs into a hot quantum tape, public neutral-atom leadership could be marked at a multiple of the current note value, in line with where logical-qubit-leading peers trade.
The number is a milestone-probability call, not an earnings multiple. The single biggest swing factor is whether the 2028 Libra FTQC demonstration lands on time; the second is quantum-sector sentiment at the note-conversion / IPO date. Treat the ~$1B as a soft, unpriced mark.
SWOT
Strengths
- 96-logical-qubit, below-threshold error-correction demonstration — a measured lead on the metric that matters
- Exclusive Harvard OTD patent license to the Lukin/Vuletić Rydberg-atom IP; Harvard/MIT/Yale research pipeline
- Google + SoftBank + NVIDIA strategic backing; ~$247M raised
- First-mover AWS Braket distribution (Aquila since 2022; Libra committed for 2028)
- Neutral-atom modality scales qubit count cheaply (no per-qubit cryo wiring); 3,000-atom continuous operation shown
Weaknesses
- Pre-commercial-scale revenue (undisclosed/immaterial); deep operating burn
- Valuation is an unpriced convertible-note mark, not a Series-N price
- Acting/interim CEO history (Andy Ory named interim CEO) — execution-team depth in scaling hardware ops still proving out
- Analog Aquila is the only shipping product; the FTQC value proposition is still 2+ years away
- Capital-intensive; dependent on continued fundraising to reach fault tolerance
Opportunities
- FTQC Libra on Braket (2028) → first error-corrected commercial neutral-atom revenue
- Hybrid quantum-classical with NVIDIA GPUs (CUDA-Q) — accelerated near-term utility
- On-prem sovereign/enterprise system sales (AIST Japan precedent; Merck, Amgen engagements)
- US/allied government quantum funding wave (DARPA QBI Stage B; potential federal equity stakes 2026)
- Eventual IPO into a hot quantum public market if fidelity milestones land
Threats
- Deep-pocketed incumbents IBM, Google, Quantinuum across modalities
- Direct neutral-atom rivals Pasqal (1,000 qubits, EU) and Atom Computing (Microsoft Azure)
- Quantum-stock bubble deflation → down-round / lower IPO multiple
- Technical risk: error-correction overhead or fidelity ceilings could stall the megaquop/gigaquop roadmap
- Modality risk: superconducting/ion-trap/photonics could out-execute neutral-atom on the path to advantage
Moats, dependencies & bottlenecks
Moats
Dependencies
Top signals & trends
Top signals
First company to show error-corrected gates across all 96 logical qubits simultaneously — a genuine lead on the metric that gates fault tolerance.
Strategic capital from the three most relevant validators; de-risks the path to the 2028 Libra system.
The ~$1B valuation is an implied secondary mark; conversion price is set later — down-round risk if quantum sentiment cools.
Credible roadmap but the commercial inflection is 2+ years out; analog Aquila is the only shipping product today.
Independent government validation + non-dilutive funding; survives a cull from a larger Stage-A field.
Evidence of the research-to-commercial transition QuEra claims for 2025 — real system sales and pharma R&D demand.
Caps the realistic exit/IPO multiple and the convertible-note conversion price; sentiment-driven, not fundamentals-driven, valuations.
Likely raises another private round (converting the note) before any IPO; not imminently public.
Trends
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
GPU/CUDA-Q for hybrid quantum-classical compute AND a strategic investor (NVentures, Sept 2025). Supplies the classical co-processing layer.
Lasers/photonics — neutral-atom systems are optics-heavy (trapping/Rydberg-excitation lasers, AOMs, optical components). Representative US laser/optics supplier.
Photonics, optics, vacuum, and motion subsystems used across atomic/quantum hardware stacks. Representative supply-chain name.
Lasers and photonic components for the optical control stack. Representative US photonics supplier.
Exclusive patent license to the Lukin/Vuletić Rydberg-atom IP — the foundational technology supplier (not a vendor, an IP licensor).
Primary cloud distribution channel — Aquila live since 2022, Libra committed 2028. AWS is both channel and de-facto largest customer-facing surface.
Enterprise R&D partner (drug discovery / materials simulation use cases).
Enterprise R&D partner (biopharma simulation).
First on-premises Gemini-class system install — a sovereign-research customer; system-sale revenue. (Analysis only — non-US.)
DARPA QBI Stage B contract (up to $15M); federal R&D + potential equity-stake demand channel.
Largest public quantum pure-play (~$130M FY25 revenue); trapped-ion modality. Different tech but competes for the same enterprise/government compute budgets and talent. Also in DARPA QBI Stage B.
Trapped-ion full-stack leader on fidelity/logical qubits; deep Honeywell balance sheet; IPO chatter. The benchmark QuEra must beat on logical-qubit quality. Also in DARPA QBI Stage B.
Superconducting roadmap to fault tolerance; vast resources, Qiskit ecosystem, enterprise reach. In DARPA QBI Stage B.
France-based; the most direct neutral-atom rival. Hit 1,000 qubits in 2024, targeting 10,000 by 2026. EU sovereign-compute tailwind. (Analysis only — non-US.)
US neutral-atom rival; Microsoft Azure Quantum partnership (Phoenix system) — the Microsoft-channel analog to QuEra's AWS channel. Private.
Superconducting modular chips; public, speculative valuation. Competes for pure-play investor capital more than for the same customers.
Quantum annealing (optimization-specialized), not universal gate-based — adjacent, not directly competitive on the FTQC roadmap. Public.
Investor AND competitor: leads QuEra's funding yet runs its own superconducting (Willow) program. Strategic backer today, potential rival on FTQC.
Neutral-atom/cold-atom peer; pursuing a public listing (SPAC filings on file 2026) — a near-term comp for QuEra's eventual valuation.